The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate
Corrigendum 2016 en
Authors
LT
Luigi Tortola
RN
Roberto Nitsch
MB
Mathieu J.M. Bertrand
Abstract
1 min read
(Cell Reports 15, 1481–1492; May 17, 2016) In the originally published version of this article, Michaela Lang, who contributed some of the data shown in Figure 7, was mistakenly omitted from the author list. The corrected version of the article now appears online. The authors regret the error. The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell FateTortola et al.Cell ReportsMay 5, 2016In BriefTortola et al. report that the E3 ubiquitin ligase HACE1 is a gatekeeper of TNFR1-mediated cell fate. Hace1 deficiency impairs TNF-driven NF-κB activation and apoptosis and predisposes cells to necroptosis. Consequently, hace1–/– mice show enhanced colitis and colon cancer, which can be reverted by inactivation of pro-necroptotic kinase RIP3 and TNFR1. Full-Text PDF Open Access
Steven Yea, Goutham Narla, Xiao Zhao, Rakhi Garg, Sigal Tal–Kremer, Eldad A. Hod, Augusto Villanueva, Johnny Loke, Mirko Tarocchi, Kunihara Akita, Senji Shirasawa, Takehiko Sasazuki, John A. Martignetti, Josep M. Llovet, Scott L. Friedman
Miguel Alaminos, Verónica Dávalos, Santiago Ropero, Fernando Setién, Maria F. Paz, Michel Herranz, Mario F. Fraga, Jaume Mora, Nai‐Kong V. Cheung, William L. Gerald, Manel Esteller
Kadriye Nehir Cosgun, Gauri Deb, Xin Yang, Gang Xiao, Teresa Sadras, Jae Woong Lee, Lai N. Chan, Kohei Kume, Lu Yang, Huimin Geng, John Chan, Joo Y. Song, Hassan Jumaa, Andrew G. Polson, Hans Clevers, Markus Müschen
Discussion(0)
No comments yet. Be the first to comment.